MEI Pharma Inc
NASDAQ:LITS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MEI Pharma Inc
NASDAQ:LITS
|
US |
|
Sartorius AG
F:SRT4
|
DE |
|
F
|
FormFactor Inc
F:FMF
|
US |
|
E
|
EnBW Energie Baden Wuerttemberg AG
F:EBK
|
DE |
|
U
|
Universal Health Services Inc
F:UHS
|
US |
|
A
|
Adocia SA
SWB:A89
|
FR |
|
A
|
Axon Enterprise Inc
DUS:TCS
|
US |
|
T
|
Tenet Healthcare Corp
SWB:THC1
|
US |
|
NCS Multistage Holdings Inc
F:MUH0
|
US |
|
G
|
Garmin Ltd
DUS:GEY
|
CH |
|
Reliq Health Technologies Inc
XTSX:RHT
|
CA |
|
Microsoft Corp
NASDAQ:MSFT
|
US |
|
O
|
Otto Energy Ltd
F:O1E
|
AU |
|
Takasago Thermal Engineering Co Ltd
F:Q74
|
JP |
|
S
|
Stryker Corp
DUS:SYK
|
US |
|
C
|
Canadian Pacific Railway Ltd
F:PC8
|
CA |
|
E
|
Exor NV
XMUN:EYX
|
NL |
|
N
|
Nippon Television Holdings Inc
XMUN:NP9
|
JP |
|
E
|
Equifax Inc
XBER:EFX
|
US |
|
T
|
TIME dotCom Bhd
KLSE:TIMECOM
|
MY |
|
W
|
Williams-Sonoma Inc
F:WM1
|
US |
|
D
|
Daimler AG
XBER:DAI
|
DE |
|
C
|
Compass Minerals International Inc
XBER:CM8
|
US |
|
R
|
Ralph Lauren Corp
XMUN:PRL
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LITS's stock price target?
Not Available
LITS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for MEI Pharma Inc?
Projected CAGR
-27%
The compound annual growth rate for Revenue over the next 3 years is -27%.